Mutagenesis of tGCN5 core region reveals two critical surface residues F90 and R140

Biochemical and Biophysical Research Communications

Volumn 400, Issue 3, 2010, Pages 363-368

  Mehta, Kinjal Rajesh ^a   Chan, Yan M ^a   Lee, Man X ^a   Yang, Ching Yao ^a   Voloshchuk, Natalya ^a   Montclare, Jin Kim ^a,b  

^a POLYTECHNIC UNIVERSITY   (United States)

^b SUNY Downstate Medical Center   (United States)

Author keywords

Histone; Histone acetyltransferase (HAT); Homology; Structural stability; TGCN5; Thermodynamic stability

Indexed keywords

HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE H3; TETRAHYMENA GENERAL CONTROL NON DEREPRESSOR 5; UNCLASSIFIED DRUG; ARGININE; CALCIUM BINDING PROTEIN; CP35 PROTEIN, COLUMBA LIVIA; PHENYLALANINE; TGCN5 HISTONE ACETYLTRANSFERASE;

ACETYLATION; ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME STABILITY; GENE CONTROL; GENETIC TRANSCRIPTION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN VARIANT; TETRAHYMENA; THERMODYNAMICS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHEMISTRY; ENZYMOLOGY; GENETICS; MOLECULAR GENETICS; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARGININE; CALCIUM-BINDING PROTEINS; ENZYME STABILITY; HISTONE ACETYLTRANSFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHENYLALANINE; TETRAHYMENA; THERMODYNAMICS;

TETRAHYMENA;

EID: 77956898817     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.069     Document Type: Article

References (38)

1. Marmostein R. Structure of histone acetyltransferases. J. Mol. Biol. 2001, 311:433-444.
2. Sterner D.E., Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 2000, 64:435-459.
3. Bannister A.J., Miska E.A. Regulation of gene expression by transcription factor acetylation. Cell. Mol. Life. Sci. 2000, 57:1184-1192.
4. Isharwal S., Miller M.C., Marlow C., Makarov D.V., Partin A.W., Veltri R.W. p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape. Prostate 2008, 68:1097-1104.
5. Guidez F., Howell L., Isalan M., Cebrat M., Alani R.M., Ivins S., Hormaeche I., McConnell M.J., Pierce S., Cole P.A., Licht J., Zelent A. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein. Mol. Cell. Biol. 2005, 25:5552-5566.
6. Pfister S., Rea S., Taipale M., Mendrzyk F., Straub B., Ittrich C., Thuerigen O., Sinn H.P., Akhtar A., Lichter P. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int. J. Cancer 2008, 122:1207-1213.
7. Murata T., Kurukawa R., Krones A., Tatsumi K., Ishii M., Taki T., Masuno M., Ohashi H.M., Yanagisawa M., Rosenfeld M.G., Glass C.K., Hayashi Y. Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome. Hum. Mol. Genet. 2001, 10:1071-1076.
8. Rojas J.R., Trievel R.C., Zhou J., Mo Y., Li X., Berger S.L., Allis C.D., Marmorstein R. Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide. Nature 1999, 401:93-98.
9. Marmorstein R. Structure and function of histone acetyltransferases. Cell. Mol. Life Sci. 2001, 58:693-703.
10. Galasinski S.C., Louie D.F., Gloor K.K., Resing K.A., Ahn N.G. Global regulation of post-translational modifications on core histones. J. Biol. Chem. 2002, 277:2579-2588.
11. Lin Y., Fletcher C.M., Zhou J., Allis C.D., Wagner G. Solution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A. Nature 1999, 400:86-89.
12. Trievel R.C., Rojas J.R., Sterner D.E., Venkataramani R.N., Wang L., Zhou J., Allis C.D., Berger S.L., Marmorstein R. Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator. Proc. Natl. Acad. Sci. USA 1999, 96:8931-8936.
13. Langer M.R., Fry C.J., Peterson C.L., Denu J.M. Modulating acetyl-CoA binding in the GCN5 family of histone acetyltransferases. J. Biol. Chem. 2002, 277:27337-27344.
14. Trievel R.C., Li F.Y., Marmorstein R. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor. Anal. Biochem. 2000, 287:319-328.
15. Kuo M.H., Zhou J., Jambeck P., Churchill M.E., Allis C.D. Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo. Genes Dev. 1998, 12:627-639.
16. Ford D.J., Essex A., Spalding T.A., Burstein E.S., Ellis J. Homologous mutations near the junction of the sixth transmembrane domain and the third extracellular loop lead to constitutive activity and enhanced agonist affinity at all muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 2002, 300:810-817.
17. Huang X.P., Prilla S., Mohr K., Ellis J. Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide. Mol. Pharmacol. 2005, 68:769-778.
18. Voloshchuk N., Zhu A.Y., Snydacker D., Montclare J.K. Positional effects of monofluorinated phenylalanines on histone acetyltransferase stability and activity. Bioorg. Med. Chem. Lett. 2009, 19:5449-5451.
19. Kirshenbaum K., Carrico I.S., Tirrell D.A. Biosynthesis of proteins incorporating a versatile set of phenylalanine analogues. Chembiochem 2002, 3:235-237.
20. Michaelis L., Menten M.L. Die Kinetik der Invertinwirkung. Biochem. Z. 1913, 49:333-369.
21. Savitzky A., Golay M.J.E. Smoothing and differentiation of data by simplified least squares procedures. Anal. Chem. 1964, 36:1627-1639.
22. Beadle B.M., Shoichet B.K. Structural bases of stability-function tradeoffs in enzymes. J. Mol. Biol. 2002, 321:285-296.
23. Woestenenk E.A., Hammarstrom M., Hard T., Berglund H. Screening methods to determine biophysical properties of proteins in structural genomics. Anal. Biochem. 2003, 318:71-79.
24. Latypov R.F., Liu D., Gunasekaran K., Harvey T.S., Razinkov V.I., Raibekas A.A. Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist. Protein Sci. 2008, 17:652-663.
25. Wolf E., Vassilev A., Makino Y., Sali A., Nakatani Y., Burley S.K. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase. Cell 1998, 94:439-449.
26. Dutnall R.N., Tafrov S.T., Sternglanz R., Ramakrishnan V. Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily. Cell 1998, 94:427-438.
27. Modis Y., Filppula S.A., Novikov D.K., Norledge B., Hiltunen J.K., Wierenga R.K. The crystal structure of dienoyl-CoA isomerase at 1.5A resolution reveals the importance of aspartate and glutamate sidechains for catalysis. Structure 1998, 6:957-970.
28. Guo H.H., Choe J., Loeb L.A. Protein tolerance to random amino acid change. Proc. Natl. Acad. Sci. USA 2004, 101:9205-9210.
29. Creighton T.E. Proteins 1993, W.H. Freeman and Company, New York. second ed.
30. Lassila J.K., Keeffe J.R., Kast P., Mayo S.L. Exhaustive mutagenesis of six secondary active-site residues in Escherichia coli chorismate mutase shows the importance of hydrophobic side chains and a helix N-capping position for stability and catalysis. Biochemistry 2007, 46:6883-6891.
31. Ellis J., Seidenberg M., Brann M.R. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol. Pharmacol. 1993, 44:583-588.
32. 2-terminal domain of phage lambda repressor. Proc. Natl. Acad. Sci. USA 1984, 81:5685-5689.
33. Gromiha M.M., An J., Kono H., Oobatake M., Uedaira H., Prabakaran P., Sarai A. ProTherm, version 2.0: thermodynamic database for proteins and mutants. Nucleic Acids Res. 2000, 28:283-285.
34. Hecht M.H., Nelson H.C., Sauer R.T. Mutations in lambda repressor's amino-terminal domain: implications for protein stability and DNA binding. Proc. Natl. Acad. Sci. USA 1983, 80:2676-2680.
35. Hecht M.H., Hehir K.M., Nelson H.C., Sturtevant J.M., Sauer R.T. Increasing and decreasing protein stability: effects of revertant substitutions on the thermal denaturation of phage lambda repressor. J. Cell. Biochem. 1985, 29:217-224.
36. Pakula A.A., Sauer R.T. Reverse hydrophobic effects relieved by amino-acid substitutions at a protein surface. Nature 1990, 344:363-364.
37. Leemhuis H., Nightingale K.P., Hollfelder F. Directed evolution of a histone acetyltransferase-enhancing thermostability, whilst maintaining catalytic activity and substrate specificity. FEBS J. 2008, 275:5635-5647.
38. Zheng Y., Mamdani F., Toptygin D., Brand L., Stivers J.T., Cole P.A. Fluorescence analysis of a dynamic loop in the PCAF/GCN5 histone acetyltransferase. Biochemistry 2005, 44:10501-10509.